| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 190.15M | 130.25M | 135.22M | 119.85M | 70.08M |
| Gross Profit | 86.47M | 87.68M | 91.74M | 79.75M | 45.54M |
| EBITDA | 53.86M | 46.43M | 49.85M | 49.00M | 10.80M |
| Net Income | -110.75M | 18.09M | 16.94M | -6.13M | -27.36M |
Balance Sheet | |||||
| Total Assets | 577.46M | 646.36M | 726.04M | 806.96M | 619.05M |
| Cash, Cash Equivalents and Short-Term Investments | 9.78M | 5.10M | 8.54M | 51.82M | 397.45M |
| Total Debt | 189.70M | 93.35M | 125.08M | 182.69M | 150.47M |
| Total Liabilities | 250.77M | 132.42M | 196.08M | 267.63M | 179.60M |
| Stockholders Equity | 391.19M | 513.94M | 529.96M | 539.32M | 439.45M |
Cash Flow | |||||
| Free Cash Flow | 39.31M | 35.14M | 40.23M | 34.95M | 7.67M |
| Operating Cash Flow | 39.54M | 43.51M | 49.56M | 39.43M | 9.78M |
| Investing Cash Flow | -73.55M | -8.08M | -34.08M | -384.19M | -27.29M |
| Financing Cash Flow | 38.65M | -38.21M | -59.17M | -9.96M | 396.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £79.36M | 54.18 | 2.93% | ― | -3.95% | 16.87% | |
70 Outperform | £475.90M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
69 Neutral | £92.56M | 152.71 | 4.75% | ― | 0.97% | -71.58% | |
67 Neutral | £140.10M | 11.95 | 8.80% | 1.68% | 6.27% | 0.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | £800.56M | 114.13 | 64.11% | ― | 18.75% | -93.75% | |
52 Neutral | £409.89M | -3.56 | -17.62% | ― | 5.83% | -663.14% |